Hims & Hers (HIMS) CLO Soleil Boughton Sells 3,458 Shares

What Happened
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 3,458 shares on September 2, 2026 at $28.33 per share, for gross proceeds of approximately $97,965. The transaction is reported as a sale (code S) and was executed as an open‑market or private sale.

Key Details

• Transaction date and price: 2026-09-02 — 3,458 shares at $28.33 per share (total ≈ $97,965).
• Filing date / period of report: Form 4 filed 2026-09-03 reporting transactions for period 2026-09-02. No indication in the provided data that the filing was late.
• Ownership after transaction: Not specified in the details you provided. (The full Form 4 may list post-transaction holdings.)
• Footnote: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Boughton on May 21, 2026.

Context
Sales under a 10b5‑1 plan are typically pre‑arranged and executed according to the plan’s schedule, which can make them more routine than ad‑hoc insider sales. This report documents a disposition of shares; it does not, by itself, indicate the insider’s view of the company’s prospects.